MedTrace Logo

Effect of Intranasal Insulin on Postoperative Cognitive Dysfunction

NCT04154449 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2019-11-06

No results posted yet for this study

Summary

Our study is designed to evaluate the effect of intranasal insulin on postoperative cognitive dysfunction.

Primary outcome:

1\. The occurrence of cognitive dysfunction at approximately 7 days after surgery.

Secondary outcome:

1\. Incidence of any side effect.

Conditions

  • Middle Aged Patients

Interventions

DRUG

Intranasal insulin

Surgical group Received intranasal insulin, the second group surgical Received placebo and the third group is non surgical do not receive anything.

Sponsors & Collaborators

  • Minia University

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-25
Primary Completion
2019-12-25
Completion
2019-12-25
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04154449 on ClinicalTrials.gov